Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$6.09

Avg closing price
Price range

6 John Paulson Biocryst Pharmaceuticals Trades

The first Biocryst Pharmaceuticals trade was made in Q1 2016. Since then John Paulson bought shares two more times and sold shares on three occasions. The investor sold all their shares in Q3 2017 and doesn't own any shares in Biocryst Pharmaceuticals anymore.

Avg closing price
Price range
Sold -350 Thousand shares Q3 2017
Avg closing price $5.12
Price range $4.10 - $5.97
New holding (+350 Thousand shares) Q2 2017
Avg closing price $6.09
Price range $5.13 - $8.30
Sold -52.6 Thousand shares Q1 2017
Avg closing price $6.96
Price range $5.49 - $9.20
Sold 85.5% shares (-311 Thousand shares) Q4 2016
Avg closing price $5.20
Price range $3.76 - $6.99
Increased shares by 38.0% (+100 Thousand shares) Q3 2016
Avg closing price $3.99
Price range $2.87 - $5.04
New holding (+263 Thousand shares) Q1 2016
Avg closing price $4.43
Price range $1.66 - $9.80

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!